Literature DB >> 8395000

Binding of myc proteins to canonical and noncanonical DNA sequences.

T K Blackwell1, J Huang, A Ma, L Kretzner, F W Alt, R N Eisenman, H Weintraub.   

Abstract

Using an in vitro binding-site selection assay, we have demonstrated that c-Myc-Max complexes bind not only to canonical CACGTG or CATGTG motifs that are flanked by variable sequences but also to noncanonical sites that consist of an internal CG or TG dinucleotide in the context of particular variations in the CA--TG consensus. None of the selected sites contain an internal TA dinucleotide, suggesting that Myc proteins necessarily bind asymmetrically in the context of a CAT half-site. The noncanonical sites can all be bound by proteins of the Myc-Max family but not necessarily by the related CACGTG- and CATGTG-binding proteins USF and TFE3. Substitution of an arginine that is conserved in these proteins into MyoD (MyoD-R) changes its binding specificity so that it recognizes CACGTG instead of the MyoD cognate sequence (CAGCTG). However, like USF and TFE3, MyoD-R does not bind to all of the noncanonical c-Myc-Max sites. Although this R substitution changes the internal dinucleotide specificity of MyoD, it does not significantly alter its wild-type binding sequence preferences at positions outside of the CA--TG motif, suggesting that it does not dramatically change other important amino acid-DNA contacts; this observation has important implications for models of basic-helix-loop-helix protein-DNA binding.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8395000      PMCID: PMC360210          DOI: 10.1128/mcb.13.9.5216-5224.1993

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  58 in total

1.  An amino-terminal c-myc domain required for neoplastic transformation activates transcription.

Authors:  G J Kato; J Barrett; M Villa-Garcia; C V Dang
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

2.  An embryonically expressed gene is a target for c-Myc regulation via the c-Myc-binding sequence.

Authors:  N Benvenisty; A Leder; A Kuo; P Leder
Journal:  Genes Dev       Date:  1992-12       Impact factor: 11.361

3.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase.

Authors:  C Tuerk; L Gold
Journal:  Science       Date:  1990-08-03       Impact factor: 47.728

Review 4.  Are myc proteins transcription factors?

Authors:  R G Collum; F W Alt
Journal:  Cancer Cells       Date:  1990-03

5.  A helix-loop-helix protein related to the immunoglobulin E box-binding proteins.

Authors:  C S Carr; P A Sharp
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

6.  Mutations that disrupt DNA binding and dimer formation in the E47 helix-loop-helix protein map to distinct domains.

Authors:  A Voronova; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

7.  Transcription factor AP-4 contains multiple dimerization domains that regulate dimer specificity.

Authors:  Y F Hu; B Lüscher; A Admon; N Mermod; R Tjian
Journal:  Genes Dev       Date:  1990-10       Impact factor: 11.361

8.  In vitro selection of RNA molecules that bind specific ligands.

Authors:  A D Ellington; J W Szostak
Journal:  Nature       Date:  1990-08-30       Impact factor: 49.962

9.  Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection.

Authors:  T K Blackwell; H Weintraub
Journal:  Science       Date:  1990-11-23       Impact factor: 47.728

10.  The adenovirus major late transcription factor USF is a member of the helix-loop-helix group of regulatory proteins and binds to DNA as a dimer.

Authors:  P D Gregor; M Sawadogo; R G Roeder
Journal:  Genes Dev       Date:  1990-10       Impact factor: 11.361

View more
  142 in total

1.  Coexamination of site-specific transcription factor binding and promoter activity in living cells.

Authors:  K E Boyd; P J Farnham
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

2.  Establishment of distinct MyoD, E2A, and twist DNA binding specificities by different basic region-DNA conformations.

Authors:  T Kophengnavong; J E Michnowicz; T K Blackwell
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

Review 3.  The Max network gone mad.

Authors:  T A Baudino; J L Cleveland
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

4.  Specificity of DNA binding of the c-Myc/Max and ARNT/ARNT dimers at the CACGTG recognition site.

Authors:  H I Swanson; J H Yang
Journal:  Nucleic Acids Res       Date:  1999-08-01       Impact factor: 16.971

5.  Transcriptional activation by ETS and leucine zipper-containing basic helix-loop-helix proteins.

Authors:  G Tian; B Erman; H Ishii; S S Gangopadhyay; R Sen
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

6.  S-phase-specific expression of the Mad3 gene in proliferating and differentiating cells.

Authors:  E J Fox; S C Wright
Journal:  Biochem J       Date:  2001-10-15       Impact factor: 3.857

7.  C-Myc is a Nrf2-interacting protein that negatively regulates phase II genes through their electrophile responsive elements.

Authors:  Smadar Levy; Henry Jay Forman
Journal:  IUBMB Life       Date:  2010-03       Impact factor: 3.885

8.  DNA double-strand breaks relieve USF-mediated repression of Dβ2 germline transcription in developing thymocytes.

Authors:  Jennifer L Stone; Ruth E McMillan; David A Skaar; Justin M Bradshaw; Randy L Jirtle; Michael L Sikes
Journal:  J Immunol       Date:  2012-01-27       Impact factor: 5.422

9.  c-Myc binds to 5' flanking sequence motifs of the dihydrofolate reductase gene in cellular extracts: role in proliferation.

Authors:  S Mai; A Jalava
Journal:  Nucleic Acids Res       Date:  1994-06-25       Impact factor: 16.971

10.  Transactivation of the human p53 tumor suppressor gene by c-Myc/Max contributes to elevated mutant p53 expression in some tumors.

Authors:  B Roy; J Beamon; E Balint; D Reisman
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.